ESSA Pharma Inc (EPIX) - Gunggung Aset Perusahaan

ESSA Pharma Inc. (EPIX) develops innovative drugs to combat gynecological tumors, minimizing strategic threats by expanding its clinical trial portfolio. High physician authority is sustained by a unique method of suppressing neoplasm growth. The linear price action on the total assets chart is fixed at 121.61, while the company strictly adheres to environmental regulations regarding chemical waste disposal.

EPIX: Aset Agregat Perusahaan ESSA Pharma Inc. 04.07.2022 - 25.10.2025

Rincian analitis perusahaan essapharma.com (EPIX)

- rega lan prakiraan konsensus rega:

Kurs saham ESSA Pharma|EPIX - Prakiraan konsensus analis

- data kapitalisasi pasar:

Biji pasar ESSA Pharma|EPIX - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham ESSA Pharma|EPIX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku essapharma.com|EPIX - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas ESSA Pharma Inc.|EPIX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal ESSA Pharma|EPIX - Utang perusahaan|Rasio utang marang aset resik ESSA Pharma|EPIX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan ESSA Pharma

Analisis kabeh metrik perusahaan:EPIX, ESSA Pharma Inc

An investment audit of ESSA Pharma Inc. (EPIX) requires an analysis of the total resource value, reverse-calculated via return on assets (ROA) as the sum of liabilities and equity. This metric reflects the financial strength of the biotech firm, where capital-intensive research and patent protection of small molecules create insurmountable barriers for competitors, as clearly evidenced by the fluctuations in total capital and liabilities.

Pesaing ESSA Pharma Inc. (EPIX)